Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, Molhoek P, Verheugt FW, Gersh BJ, McCabe CH, Braunwald E. Scirica BM, et al. Among authors: molhoek p. Circulation. 2007 Oct 9;116(15):1647-52. doi: 10.1161/CIRCULATIONAHA.107.724880. Epub 2007 Sep 5. Circulation. 2007. PMID: 17804441 Clinical Trial.
Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial.
Gibson CM, Zorkun C, Molhoek P, Zmudka K, Greenberg M, Mueller H, Wesdorp J, Louwerenburg H, Niederman A, Westenburg J, Bikkina M, Batty J, de Winter J, Murphy SA, McCabe CH. Gibson CM, et al. Among authors: molhoek p. J Thromb Thrombolysis. 2006 Aug;22(1):13-21. doi: 10.1007/s11239-006-8080-1. J Thromb Thrombolysis. 2006. PMID: 16786228 Clinical Trial.
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis.
Giraldez RR, Nicolau JC, Corbalan R, Gurfinkel EP, Juarez U, Lopez-Sendon J, Parkhomenko A, Molhoek P, Mohanavelu S, Morrow DA, Antman EM. Giraldez RR, et al. Among authors: molhoek p. Eur Heart J. 2007 Jul;28(13):1566-73. doi: 10.1093/eurheartj/ehm179. Epub 2007 Jun 11. Eur Heart J. 2007. PMID: 17562672 Clinical Trial.
Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II).
Ross AM, Molhoek P, Lundergan C, Knudtson M, Draoui Y, Regalado L, Le Louer V, Bigonzi F, Schwartz W, de Jong E, Coyne K; HART II Investigators. Ross AM, et al. Among authors: molhoek p. Circulation. 2001 Aug 7;104(6):648-52. doi: 10.1161/hc3101.093866. Circulation. 2001. PMID: 11489769 Clinical Trial.
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ, Spickler W, Théroux P, White H, Gibson M, Molhoek PG, Anderson HV, Weitz JI, Hirsh J, Weaver WD. Peters RJ, et al. Among authors: molhoek pg. Am Heart J. 2001 Aug;142(2):237-43. doi: 10.1067/mhj.2001.116759. Am Heart J. 2001. PMID: 11479461 Clinical Trial.
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
Armstrong PW, Burton J, Pakola S, Molhoek PG, Betriu A, Tendera M, Bode C, Adgey AA, Bar F, Vahanian A, Van de Werf F; CAPTORS II Investigators. Armstrong PW, et al. Among authors: molhoek pg. Am Heart J. 2003 Sep;146(3):484-8. doi: 10.1016/S0002-8703(03)00312-0. Am Heart J. 2003. PMID: 12947367 Clinical Trial.
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study.
Ronner E, van Kesteren HA, Zijnen P, Altmann E, Molhoek PG, van der Wieken LR, Cuffie-Jackson CA, Neuhaus KL, Simoons ML. Ronner E, et al. Among authors: molhoek pg. Eur Heart J. 2000 Sep;21(18):1530-6. doi: 10.1053/euhj.1999.2035. Eur Heart J. 2000. PMID: 10973767 Clinical Trial.